Challenges and Pitfalls in Patch Testing: Medications, Angry Back, Counseling, and Systemic Contact Dermatitis

Conclusions

• Active dermatitis should be controlled before patch testing because testing on inflamed skin increases the risk of angry back and misleading results.
• Methotrexate appears to have the least effect on patch testing among common systemic treatments, whereas prednisone is more likely to suppress or weaken reactions.
• Dupilumab and especially JAK inhibitors can reduce or eliminate some positive patch test reactions, so results on these therapies require caution in interpretation.
• If patients cannot stop systemic therapy, patch testing can still be done at the lowest effective immunosuppressive dose, with awareness that weak or false-negative reactions may occur.
• Angry back or excited skin syndrome can produce false positives, so delayed readings around 96 hours or later and retesting may be necessary.
• Counseling is a major part of patch testing, and providing safe-product lists, handouts, and CAMP resources improves adherence and outcomes.
• Patients often remember only part of their allergens, so repeated review of allergens over time is important because recall decreases as the number of allergens increases.
• Patch testing is helpful overall, with most patients reporting improvement and many recommending it to others.
• If dermatitis persists after patch testing, clinicians should consider ongoing exposure, missed allergens, systemic contact dermatitis, or another skin diagnosis.
• Systemic contact dermatitis is uncommon but real, with nickel and balsam of Peru/fragrance among the most frequent triggers and diet avoidance helping selected patients.
• Limited baseline panels can miss clinically relevant and occupational allergens, so expanded or customized testing to patient products is often necessary.
• Overall, patch testing remains an important and worthwhile tool for diagnosing allergic contact dermatitis and improving quality of life when performed and interpreted thoughtfully.